Pierre‐Antoine Juge

<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

Pierre‐Antoine Juge, Joyce Lee, Esther Ebstein et al. · New England Journal of Medicine · 2018 · 475 citations · Full text

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis

Pierre‐Antoine Juge, Raphaël Borie, Caroline Kannengiesser et al. · European Respiratory Journal · 2017 · 225 citations · Full text

A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease

Pierre‐Antoine Juge, Benjamin Granger, Marie‐Pierre Debray et al. · Arthritis & Rheumatology · 2022 · 100 citations · Full text

Regulator of telomere length 1 (<i>RTEL1</i>) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes

Raphaël Borie, Diane Bouvry, Vincent Cottin et al. · European Respiratory Journal · 2018 · 69 citations · Full text